secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOCEPT INC (—)
CIK:        0001044378
Form:       8-K
Filed at:   2023-10-20T23:59:59+00:00
Accession:  0001654954-23-013182
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biocept to be delisted from Nasdaq after Chapter 7 bankruptcy filing
--------------------------------------------------------------------

- Company filed Chapter 7 bankruptcy on October 13, 2023 in Delaware District Court.
- Nasdaq delisting notice received October 16, 2023 citing public interest and equity concerns.
- Trading of common stock and warrants suspended at market open on October 25, 2023.
- Company will not appeal the delisting determination.
- Caution that holders of common stock will likely experience a significant or total loss.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1044378/000165495423013182/0001654954-23-013182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1044378/000165495423013182/biocept_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-013182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer